Russell Investments Group, Ltd. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2022$487,000
-23.2%
300,427
-62.5%
0.00%0.0%
Q2 2022$634,000
-58.9%
800,661
-6.8%
0.00%
-66.7%
Q1 2022$1,544,000
-1.3%
859,039
-6.2%
0.00%
+50.0%
Q4 2021$1,564,000
+56.1%
915,745
+87.9%
0.00%0.0%
Q3 2021$1,002,000
-21.5%
487,270
-12.0%
0.00%0.0%
Q2 2021$1,276,000
-19.5%
553,592
-2.7%
0.00%
-33.3%
Q1 2021$1,586,000
-1.7%
569,022
+0.3%
0.00%0.0%
Q4 2020$1,614,000
+1693.3%
567,258
+1200.0%
0.00%
Q3 2020$90,000
-89.1%
43,634
-76.1%
0.00%
-100.0%
Q2 2020$828,000
+114.5%
182,406
+284.5%
0.00%
+100.0%
Q1 2020$386,000
-81.1%
47,438
-57.4%
0.00%
-75.0%
Q4 2019$2,043,000
+391.1%
111,459
+196.9%
0.00%
+300.0%
Q3 2019$416,000
+766.7%
37,544
+674.4%
0.00%
Q2 2019$48,000
+29.7%
4,848
-34.9%
0.00%
Q2 2018$37,000
+117.6%
7,443
+396.2%
0.00%
Q1 2018$17,0001,5000.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Engine Capital Management, LP 872,494$6,195,0003.64%
Newtyn Management, LLC 1,600,000$11,360,0002.22%
Broadfin Capital, LLC 2,048,025$14,541,0001.91%
Balter Liquid Alternatives, LLC 92,167$654,0000.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 515,414$3,660,0000.29%
JT Stratford LLC 45,367$322,0000.21%
Opus Point Partners Management, LLC 11,353$81,0000.18%
Alyeska Investment Group, L.P. 964,000$6,844,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 500,625$3,554,0000.09%
Monarch Partners Asset Management LLC 55,857$397,0000.06%
View complete list of RECRO PHARMA INC shareholders